iShares U.S. Pharmaceuticals ETF
Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
IHE price
Table
| Date | IHE close |
|---|---|
| Sep 28, 2026 | $103.19 |
| Sep 29, 2026 | $102.26 |
| Sep 30, 2026 | $100.52 |
| Oct 1, 2026 | $99.00 |
| Oct 2, 2026 | $98.65 |
| Oct 5, 2026 | $98.22 |
| Oct 6, 2026 | $98.34 |
| Oct 7, 2026 | $99.39 |
| Oct 8, 2026 | $98.86 |
| Oct 9, 2026 | $100.09 |
| Oct 12, 2026 | $100.19 |
| Oct 13, 2026 | $97.36 |
| Oct 14, 2026 | $99.49 |
| Oct 15, 2026 | $101.12 |
| Oct 16, 2026 | $101.06 |
| Oct 19, 2026 | $100.58 |
| Oct 20, 2026 | $103.47 |
| Oct 21, 2026 | $102.78 |
| Oct 22, 2026 | $104.78 |
| Oct 23, 2026 | $102.51 |
| Oct 26, 2026 | $102.81 |
| Oct 27, 2026 | $103.35 |
Daily net flows, 1M
Net outflow over the range: −$130M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Sep 28 | $0 |
| Sep 29 | −$5.1M |
| Sep 30 | $0 |
| Oct 1 | $5M |
| Oct 2 | $0 |
| Oct 5 | −$39.2M |
| Oct 6 | −$24.5M |
| Oct 7 | −$19.8M |
| Oct 8 | $8.6M |
| Oct 9 | $1.2M |
| Oct 12 | $0 |
| Oct 13 | $44M |
| Oct 14 | −$81.7M |
| Oct 15 | $7.1M |
| Oct 16 | $1.2M |
| Oct 19 | $7.3M |
| Oct 20 | −$18.4M |
| Oct 21 | −$10.3M |
| Oct 22 | $0 |
| Oct 23 | $0 |
| Oct 26 | −$5.1M |
Money is leaving — −$130M in net outflows over the past month, about 8.4% of the fund's asset base, while the price has returned +21.8% so far this year. At 0.40% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 25.34% | $1281.91 | +0.2% | ||
| 2 | JNJJOHNSON & JOHNSON | 22.10% | $268.73 | +0.9% | ||
| 3 | RPRXROYALTY PHARMA | 4.72% | $65.28 | +0.8% | ||
| 4 | PFEPFIZER | 4.84% | $29.80 | +0.0% | ||
| 5 | ZTSZOETIS | 4.95% | $78.23 | -3.4% | ||
| 6 | VTRSVIATRIS | 4.53% | $18.72 | +2.4% | ||
| 7 | MRKMERCK & CO | 4.41% | $141.82 | +0.9% | ||
| 8 | BMYBRISTOL MYERS SQUIBB | 4.27% | $61.55 | -0.1% | ||
| 9 | JAZZJAZZ PHARMACEUTICALS | 3.04% | $206.78 | +0.5% | ||
| 10 | ELANELANCO ANIMAL HEALTH | 2.47% | $22.65 | -1.4% | ||
| 11 | CORTCORCEPT THERAPEUTICS | 1.79% | $87.59 | +0.5% | ||
| 12 | AXSMAXSOME THERAPEUTICS | 1.42% | $142.20 | -1.3% | ||
| 13 | LGNDLIGAND PHARMACEUTICALS | 1.33% | $311.73 | +1.1% | ||
| 14 | DFTXDefinium Therapeutics | 1.05% | $37.08 | +3.9% | ||
| 15 | MANEVERADERMICS INC | 0.95% | $140.72 | +2.4% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 38Sector weights
- Health Care99.91%
- Cash and/or Derivatives0.07%
Show as table
| Item | Value (%) |
|---|---|
| Health Care | 99.91% |
| Cash and/or Derivatives | 0.07% |
| 1 week | +0.6% |
| 1 month | +0.8% |
| 3 months | +0.4% |
| 6 months | +20.1% |
| YTD | +21.8% |
| 1 year | +37.6% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$15M |
| 1 month | −$130M |
| 3 months | −$46M |
| YTD | +$502M |
| 1 year | +$666M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct | $3.8M |
| Nov | $113M |
| Dec | $50.3M |
| Jan | $101.5M |
| Feb | $35.9M |
| Mar | −$4.4M |
| Apr | −$65.2M |
| May | −$80M |
| Jul | $637.7M |
| Aug | −$13.3M |
| Sep | $14.8M |
| Oct | −$124.5M |
The top holding is 25.3% of the book; the top ten carry 81%. Spread across 55+ names, it behaves like roughly 8 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $24M | $26M |
| MRK MERCK & CO | $3M | $4M |
| JNJ JOHNSON & JOHNSON | $4M | $3M |
| LQDA LIQUIDIA | $2M | $3M |
| PFE PFIZER | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IHE on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -37bp on fee · 26× the assets · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -37bp on fee · 12× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -36bp on fee · 21× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$47M | -36bp on fee · 15× the assets · +$47M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -36bp on fee · 12× the assets · +$412M in over the month | Head-to-head |